Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies

Author(s):  
Soong Ho Kim ◽  
Kurt Farrell ◽  
Stephanie Cosentino ◽  
Jean-Paul G Vonsattel ◽  
Phyllis L Faust ◽  
...  

Abstract Patients with essential tremor (ET) frequently develop concurrent dementia, which is often assumed to represent co-morbid Alzheimer disease (AD). Autopsy studies have identified a spectrum of tau pathologies in ET and tau isoforms have not been examined in ET. We performed immunoblotting using autopsy cerebral cortical tissue from patients with ET (n = 13), progressive supranuclear palsy ([PSP], n = 10), Pick disease ([PiD], n = 2), and AD (n = 7). Total tau in ET samples was similar to that in PSP and PiD but was significantly lower than that in AD. Abnormal tau levels measured using the AT8 phospho-tau specific (S202/T205/S208) monoclonal antibody in ET were similar to those in PSP but were lower than in PiD and AD. In aggregates, tau with 3 microtubule-binding domain repeats (3R) was significantly higher in AD than ET, while tau with 4 repeats (4R) was significantly higher in PSP. Strikingly, the total tau without N-terminal inserts in ET was significantly lower than in PSP, PiD, and AD, but total tau with other N-terminal inserts was not. Monomeric tau with one insert in ET was similar to that in PSP and PiD was lower than in AD. Thus, ET brains exhibit an expression profile of tau protein isoforms that diverges from that of other tauopathies.

2010 ◽  
Vol 33 (8) ◽  
pp. 1090-1098 ◽  
Author(s):  
Diego Bohoyo ◽  
Isabelle Le Potier ◽  
Céline Rivière ◽  
Hans Klafki ◽  
Jens Wiltfang ◽  
...  

2000 ◽  
Vol 33 (1) ◽  
pp. 95-130 ◽  
Author(s):  
Luc Buée ◽  
Thierry Bussière ◽  
Valérie Buée-Scherrer ◽  
André Delacourte ◽  
Patrick R. Hof

Hippocampus ◽  
2007 ◽  
Vol 17 (2) ◽  
pp. 98-102 ◽  
Author(s):  
Torsten Bullmann ◽  
Rohan de Silva ◽  
Max Holzer ◽  
Hiroshi Mori ◽  
Thomas Arendt

2002 ◽  
Vol 104 (4) ◽  
pp. 425-434 ◽  
Author(s):  
Markus Tolnay ◽  
Nicolas Sergeant ◽  
Antoine Ghestem ◽  
Sonia Chalbot ◽  
Rob A. de Vos ◽  
...  

Lab on a Chip ◽  
2013 ◽  
Vol 13 (16) ◽  
pp. 3217 ◽  
Author(s):  
Mehmet C. Tarhan ◽  
Yslam Orazov ◽  
Ryuji Yokokawa ◽  
Stanislav L. Karsten ◽  
Hiroyuki Fujita

FEBS Letters ◽  
1997 ◽  
Vol 412 (3) ◽  
pp. 578-582 ◽  
Author(s):  
N Sergeant ◽  
J.-P David ◽  
D Lefranc ◽  
P Vermersch ◽  
A Wattez ◽  
...  

2006 ◽  
Vol 14 (7S_Part_5) ◽  
pp. P320-P320
Author(s):  
Yusaku Hioki ◽  
Naoki Kaneko ◽  
Ritsuko Yoda ◽  
Sadanori Sekiya ◽  
Shinichi Iwamoto ◽  
...  

2006 ◽  
Vol 2 ◽  
pp. S465-S465
Author(s):  
Rohan de Silva ◽  
Tammaryn Lashley ◽  
Catherine Strand ◽  
Anna-Maria Shiarli ◽  
Tamas Revesz ◽  
...  

2011 ◽  
Vol 17 (9) ◽  
pp. 714-715 ◽  
Author(s):  
Radu Constantinescu ◽  
Megan Romer ◽  
Henrik Zetterberg ◽  
Lars Rosengren ◽  
Karl Kieburtz

2021 ◽  
Vol 79 (4) ◽  
pp. 1517-1531
Author(s):  
Alejandra Martínez-Maldonado ◽  
Miguel Ángel Ontiveros-Torres ◽  
Charles R. Harrington ◽  
José Francisco Montiel-Sosa ◽  
Raúl García-Tapia Prandiz ◽  
...  

Background: Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP) are examples of neurodegenerative diseases, characterized by abnormal tau inclusions, that are called tauopathies. AD is characterized by highly insoluble paired helical filaments (PHFs) composed of tau with abnormal post-translational modifications. PSP is a neurodegenerative disease with pathological and clinical heterogeneity. There are six tau isoforms expressed in the adult human brain, with repeated microtubule-binding domains of three (3R) or four (4R) repeats. In AD, the 4R:3R ratio is 1:1. In PSP, the 4R isoform predominates. The lesions in PSP brains contain phosphorylated tau aggregates in both neurons and glial cells. Objective: Our objective was to evaluate and compare the processing of pathological tau in PSP and AD. Methods: Double and triple immunofluorescent labeling with antibodies to specific post-translational tau modifications (phosphorylation, truncation, and conformational changes) and thiazin red (TR) staining were carried out and analyzed by confocal microscopy. Results: Our results showed that PSP was characterized by phosphorylated tau in neurofibrillary tangles (NFTs) and glial cells. Tau truncated at either Glu391 or Asp421 was not observed. Extracellular NFTs (eNFTs) and glial cells in PSP exhibited a strong affinity for TR in the absence of intact or phosphorylated tau. Conclusion: Phosphorylated tau was as abundant in PSP as in AD. The development of eNFTs from both glial cells and neuronal bodies suggests that truncated tau species, different from those observed in AD, could be present in PSP. Additional studies on truncated tau within PSP lesions could improve our understanding of the pathological processing of tau and help identify a discriminatory biomarker for AD and PSP.


Sign in / Sign up

Export Citation Format

Share Document